Safety and efficacy of bronchial thermoplasty in refractory asthma with severe obstructive respiratory dysfunction
Therapeutic Advances in Respiratory Disease · 2024-01 · 18
DOI: 10.1177/17534666241254980 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 28.05.2024. Verfasst von Takahiro Inoue und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Fujita Health University School of Medicine, Kutsukake-cho, Toyoake, Aichi, Japan. Hauptthemen laut MEDLINE: Bronchial Thermoplasty, Asthma, Severity of Illness Index, Lung. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Bronchial thermoplasty (BT) is a recently developed non-pharmacological therapy for refractory bronchial asthma. Although increasing evidence has suggested that BT is effective for various phenotypes of severe asthma, its safety and efficacy in patients with severe irreversible impaired lung function are unclear.
Objectives
To assess the efficacy and safety of BT in patients with refractory asthma, including patients with a severely impaired forced expiratory volume in 1 second (FEV1).
Design
This was a single-center, retrospective, observational cohort study.
Methods
We retrospectively reviewed the medical records of 15 patients with refractory asthma (Global Initiative for Asthma step 4 or 5), including patients with severely impaired airflow limitation (% predicted pre-bronchodilator FEV1 2 years) of BT were identified in G1 and G2 ( n = 2, 33.3% and n = 4, 44.4%, respectively).
Conclusion
BT in patients with refractory asthma and severe airflow limitation is equally safe and efficacious as that in patients with moderate airflow limitation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Fujita Health University School of Medicine, Kutsukake-cho, Toyoake, Aichi, Japan.
- Department of Respiratory Medicine, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.
- Support Office for Bioresource Research, Research Promotion Headquarters, Fujita Health University, Kutsukake-cho, Toyoake, Aichi, Japan.
ORCID-Profile: Kazuyoshi Imaizumi
Zitieren
APA
Inoue, T., Isogai, S., Yamamoto, N., Hiramatsu, N., Niwa, Y., Takahashi, H., Kimura, Y., Horiguchi, T., Goto, Y., Hashimoto, N., & Imaizumi, K. (2024). Safety and efficacy of bronchial thermoplasty in refractory asthma with severe obstructive respiratory dysfunction. Therapeutic Advances in Respiratory Disease, 18. https://doi.org/10.1177/17534666241254980
Vancouver
Inoue T, Isogai S, Yamamoto N, Hiramatsu N, Niwa Y, Takahashi H, et al. Safety and efficacy of bronchial thermoplasty in refractory asthma with severe obstructive respiratory dysfunction. Therapeutic Advances in Respiratory Disease. 2024;18. doi:10.1177/17534666241254980
BibTeX
@article{Inoue2024,
author = {Inoue, Takahiro and Isogai, Sumito and Yamamoto, Naoki and Hiramatsu, Noriko and Niwa, Yoshikazu and Takahashi, Hideaki and Kimura, Yutaro and Horiguchi, Tomoya and Goto, Yasuhiro and Hashimoto, Naozumi and Imaizumi, Kazuyoshi},
title = {Safety and efficacy of bronchial thermoplasty in refractory asthma with severe obstructive respiratory dysfunction},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2024},
volume = {18},
doi = {10.1177/17534666241254980}
}
EUVIMED